donderdag 22 maart 2012 - Nederlandse Vereniging voor Gastro ...

Donderdag 22 maart 2012
16.10 Prospective evaluation of the incidence and prevalence of exocrine pancreatic
insufficiency in patients with irresectable pancreatic adenocarcinoma
E.C.M. Sikkens¹, D.L. Cahen¹, C. van Eijck², E.J. Kuipers¹, M.J. Bruno¹, ¹Dept. of Gastroenterology,
Erasmus Medical Center, Rotterdam, ²Dept. of Surgery, Erasmus Medical Center,
Rotterdam, The Netherlands
16.20 Tumor progression after preoperative portal vein embolization
L.T. Hoekstra 1 , K.P. van Lienden 2 , A. Doets 1 , O.R.C. Busch 1 , D.J. Gouma 1 , T.M. van Gulik 1 ,
1Dept. of Surgery, Academic Medical Center, Amsterdam, 2 Dept. of Radiology, Academic
Medical Center, Amsterdam, The Netherlands
16.30 PET/CT using 18 F-fluoromethylcholine to detect hepatocellular carcinoma and assess
extent of the disease
M. Bieze 1 , H.J. Klumpen 2 , J. Verheij 5 , S.D. Hemelrijk 1 , U.H.W. Beuers 3 , P.S.L. Jansen 3 ,
S.S.K.S. Phoa 4 , Y. El Massoudi 1 , T.M. van Gulik 1 , R.J. Bennink 6 , 1 Dept. of Surgery, Academic
Medical Center, 2 Dept. of Medical Oncology, Academic Medical Center, 3 Dept. of
Hepatology, Academic Medical Center, 4 Dept. of Radiology, Academic Medical Center,
5Dept. of Pathology, Academic Medical Center, 6 Dept. of Nuclear Medicine, Academic
Medical Center, The Netherlands
16.40 The diagnostic value of the double duct sign in patients with a periampullary lesion
J.C.E.M. ten Berge 1* , M. Suker 1* , M.J. Bruno 2 , J.W. Poley 2 , S. Spronk 3 , R.S. Dwarkasing 4 , K.
Biermann 5 , C.H.J. van Eijck 1 , 1 Erasmus University Medical Center, Dept. of Surgery,
Rotterdam, 2 Erasmus University Medical Center, Dept. of Gastroenterology and Hepatology,
Rotterdam, 3 Erasmus University Medical Centre, Dept. of Radiology and Dept. of
Epidemiology, Rotterdam, 4 Erasmus University Medical Centre, Dept. of Radiology,
Rotterdam, 5 Erasmus University Medical Centre, Dept. of Pathology, Rotterdam, The
Netherlands * Both authors attributed equally
16.50 Factors determining long-term survival after HIPEC
B. Mirck 1 , S.C. Bruin 1 , Dr. M.L.F. van Velthuysen 2 , Dr. V.J. Verwaal 1 , 1 Chirurgische oncologie,
Nederlands Kanker Instituut - Antoni van Leeuwenhoek Ziekenhuis, 2 Pathologie, Nederlands
Kanker Instituut - Antoni van Leeuwenhoek Ziekenhuis, The Netherlands
Plenaire sessie
Brabantzaal
Frieda den Hartog Jager Lecture
17.00 ‘Ruim 30 jaar (erfelijk) darmkanker onderzoek’
Dr. F.M. Nagengast, maag-darm-leverarts,
Universitair Medisch Centrum St. Radboud, Nijmegen
16